BIOMARIN PHARMACEUTICAL INC (BMRN) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2009: $594.98M2010: $545.37M2011: $532.66M2012: $552.58M2013: $903.02M2014: $947.49M2015: $1.33B2016: $1.26B2017: $1.82B2018: $1.46B2019: $1.57B2020: $1.74B2021: $1.74B2022: $1.77B2023: $1.89B2024: $1.33B2025: $1.51B$1.51B
2009Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$1.51B+13.2%
2024$1.33B-29.6%
2023$1.89B+6.7%
2022$1.77B+1.9%
2021$1.74B-0.2%
2020$1.74B+11.1%
2019$1.57B+7.4%
2018$1.46B-20.0%
2017$1.82B+45.1%
2016$1.26B-5.4%
2015$1.33B+40.2%
2014$947.49M+4.9%
2013$903.02M+63.4%
2012$552.58M+3.7%
2011$532.66M-2.3%
2010$545.37M-8.3%
2009$594.98M